I-Mab Bags AbbVie Partnership, Nets $418M From Investors
AbbVie will pay up to $1.94 billion in a partnership to develop and commercialize a cancer treatment discovered by I-Mab, in an agreement that comes the same day the Chinese biotech...To view the full article, register now.
Already a subscriber? Click here to view full article